Vascular endothelial growth factor concentrations in serum of patients with extensive slow-flow vascular malformations

被引：0
作者：
Ferrero, S. [1 ,2 ]
机构：
[1] San Martino Hosp, Dept Obstet & Gynecol, I-16132 Genoa, Italy
[2] Univ Genoa, I-16132 Genoa, Italy
来源：
BRITISH JOURNAL OF DERMATOLOGY | 2010年 / 162卷 / 05期
关键词：
plasma; serum; vascular endothelial growth factor; vascular malformations; VEGF-C; VEGF-D; FACTOR VEGF; PERIPHERAL-BLOOD; PLATELETS;
D O I：
10.1111/j.1365-2133.2010.09690.x
中图分类号：
R75 [皮肤病学与性病学];
学科分类号：
100206 ;
摘要：
引用
收藏
页码：1155 / 1156
页数：2
相关论文
共 6 条
  • [1] Release of the angiogenic cytokine vascular endothelial growth factor (VEGF) from platelets: significance for VEGF measurements and cancer biology
    Banks, RE
    Forbes, MA
    Kinsey, SE
    Stanley, A
    Ingham, E
    Walters, C
    Selby, PJ
    [J]. BRITISH JOURNAL OF CANCER, 1998, 77 (06) : 956 - 964
  • [2] A critical review of vascular endothelial growth factor (VEGF) analysis in peripheral blood: Is the current literature meaningful?
    Hormbrey, E
    Gillespie, P
    Turner, K
    Han, C
    Roberts, A
    McGrouther, D
    Harris, AL
    [J]. CLINICAL & EXPERIMENTAL METASTASIS, 2002, 19 (08) : 651 - 663
  • [3] Angiogenic and prothrombotic markers in extensive slow-flow vascular malformations: implications for antiangiogenic/antithrombotic strategies
    Redondo, P.
    Aguado, L.
    Marquina, M.
    Paramo, J. A.
    Sierra, A.
    Sanchez-Ibarrola, A.
    Martinez-Cuesta, A.
    Cabrera, J.
    [J]. BRITISH JOURNAL OF DERMATOLOGY, 2010, 162 (02) : 350 - 356
  • [4] Peripheral blood platelets express VEGF-C and VEGF which are released during platelet activation
    Wartiovaara, U
    Salven, P
    Mikkola, H
    Lassila, R
    Kaukonen, J
    Joukov, V
    Orpana, A
    Ristimäki, A
    Heikinheimo, M
    Joensuu, H
    Alitalo, K
    Palotie, A
    [J]. THROMBOSIS AND HAEMOSTASIS, 1998, 80 (01) : 171 - 175
  • [5] Vascular endothelial growth factor (VEGF) is released from platelets during blood clotting: implications for measurement of circulating VEGF levels in clinical disease
    Webb, NJA
    Bottomley, MJ
    Watson, CJ
    Brenchley, PEC
    [J]. CLINICAL SCIENCE, 1998, 94 (04) : 395 - 404
  • [6] Vascular endothelial growth factor measured in platelet poor plasma allows optimal separation between cancer patients and volunteers:: A key to study an angiogenic marker in vivo?
    Wynendaele, W
    Derua, R
    Hoylaerts, MF
    Pawinski, A
    Waelkens, E
    de Bruijn, EA
    Paridaens, R
    Merlevede, W
    van Oosterom, AT
    [J]. ANNALS OF ONCOLOGY, 1999, 10 (08) : 965 - 971
1